603 RSUs granted to Nutex Health (NUTX) director Michael Lee Reed

Rhea-AI Filing Summary

Nutex Health, Inc. director Michael Lee Reed received an equity grant of 603 restricted stock units (RSUs) on July 14, 2025. Each RSU represents the right to receive one share of Nutex common stock with $0.001 par value upon vesting, for no cash exercise price.

The 603 RSUs are scheduled to vest 100% on July 14, 2026. If Reed leaves the company without cause before that date, the RSUs will vest on a pro-rata basis according to his actual time in service during the vesting period. After this grant, Reed beneficially owns 603 RSUs directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Reed Michael Lee

(Last) (First) (Middle)

6030 S. RICE AVE., SUITE C

(Street)

HOUSTON TX 77081

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Nutex Health, Inc. [ NUTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/14/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units (RSUs)	$0(1)	07/14/2025		A		603(1)		07/14/2026(2)	07/14/2026(2)	Common Stock	603	$0	603	D

Explanation of Responses:

1. Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

2. On July 14, 2025, the Reporting Person was granted 603 RSUs, which vest 100% on July 14, 2026. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company.

	/s/ Michael Reed	02/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider equity award did Nutex Health (NUTX) report for Michael Lee Reed?

Nutex Health reported that director Michael Lee Reed received 603 restricted stock units (RSUs). Each RSU is a right to one share of common stock with $0.001 par value, granted as equity compensation rather than a cash purchase.

When do Michael Lee Reed’s 603 Nutex Health (NUTX) RSUs vest?

The 603 RSUs granted to Michael Lee Reed vest 100% on July 14, 2026. This means all units convert into common shares on that date, assuming continued qualifying service with Nutex Health throughout the one-year vesting period.

Is the Nutex Health (NUTX) RSU grant to Michael Lee Reed a cash transaction?

No, the RSU grant to Michael Lee Reed is not a cash transaction. The Form 4 shows a price per unit of $0.0000, meaning he pays no cash to receive the shares when the restricted stock units vest into common stock.

What happens to Michael Lee Reed’s Nutex Health (NUTX) RSUs if he leaves early?

If Michael Lee Reed leaves Nutex Health without cause during the vesting period, his 603 RSUs vest on a pro-rata basis. The vested portion will reflect his actual time in service between the July 14, 2025 grant date and the July 14, 2026 vesting date.

How many Nutex Health (NUTX) RSUs does Michael Lee Reed own after this filing?

After the reported transaction, Michael Lee Reed beneficially owns 603 RSUs directly. These restricted stock units each correspond to one share of Nutex Health common stock, subject to the vesting schedule and employment conditions described in the Form 4 footnotes.